eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
4/2018
vol. 4
 
Share:
Share:
more
 
 
abstract:
Review paper

What family practitioners ought to know about management of Helicobacter pylori infection

Wiktor Łaszewicz

Online publish date: 2018/10/15
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
This article reviews the current recommendations for diagnosis and management of Helicobacter pylori (Hp) infection based on agreement in the Maastricht V/Florence Consensus Report and the Kyoto Global Consensus on Hp gastritis. It was underlined that Hp gastritis is accepted as an infectious disease irrespective of symptoms and complications. Helicobacter pylori-associated dyspepsia is a distinct entity. Helicobacter pylori infection is a major aetiological factor for gastric cancer, and Hp eradication reduces the risk of cancer development. PPI-clarithromycin-containing triple therapy should be abandoned when the clarithromycin resistance rate in the region is more than 15%. In these areas bismuth quadruple or non-bismuth quadruple therapies are recommended. In areas of high dual clarithromycin and metronidazole resistance, bismuth quadruple therapy is the recommended first-line treatment. It is worth underlining that every patient should be individually considered according to the kind of treatment and its likely complications.
keywords:

Helicobacter pylori, diagnosis of infection, management of infection

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.